0,548  0,015  GABA C receptor rho-3 antagonist
0,536  0,004  Toxic, respiratory center
0,446  0,014  Myocardial infarction treatment
0,459  0,045  Histamine release inhibitor
0,446  0,041  Stroke treatment
0,415  0,014  Cyclic AMP phosphodiesterase inhibitor
0,417  0,086  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,378  0,073  MAP kinase kinase 6 inhibitor
0,323  0,018  Pneumotoxic
0,309  0,023  Male reproductive disfunction treatment
0,321  0,035  Anticonvulsant
0,344  0,065  FMO1 substrate
0,296  0,027  Ca2+/calmodulin-dependent kinase IV inhibitor
0,367  0,105  Calcium channel L-type activator
0,305  0,047  Heart failure treatment
0,362  0,105  5 Hydroxytryptamine release inhibitor
0,305  0,060  FMO3 substrate
0,313  0,071  Anxiolytic
0,267  0,025  Cytidine deaminase inhibitor
0,332  0,091  Ulceration
0,246  0,023  Phosphodiesterase inhibitor
0,229  0,009  Antiprotozoal (Babesia)
0,272  0,055  Antineoplastic (lymphocytic leukemia)
0,287  0,071  Antituberculosic
0,238  0,027  Erectile dysfunction treatment
0,296  0,091  Vasodilator, coronary
0,274  0,073  Huntington's disease treatment
0,219  0,020  Cystathionine beta-synthase inhibitor
0,243  0,045  Antimigraine
0,207  0,010  Phosphodiesterase I inhibitor
0,194  0,006  Phosphodiesterase 5A inhibitor
0,204  0,017  Movement disorders treatment
0,268  0,083  Spasmolytic
0,191  0,006  Phosphodiesterase V inhibitor
0,205  0,026  GABA C receptor rho-2 antagonist
0,204  0,026  Antinephritic
0,196  0,023  Ferrochelatase inhibitor
0,251  0,081  Flavin-containing monooxygenase substrate
0,172  0,004  Phosphodiesterase 1A inhibitor
0,178  0,011  Phosphodiesterase 3A inhibitor
0,174  0,012  Ankylosing spondylitis treatment
0,235  0,084  Tyrosine 3 hydroxylase inhibitor
0,254  0,106  Antimycobacterial
0,262  0,116  Apoptosis antagonist
0,282  0,136  Atherosclerosis treatment
0,217  0,074  Antiparkinsonian, rigidity relieving
0,242  0,106  CYP1A2 substrate
0,235  0,100  Renal disease treatment
0,179  0,048  Skeletal muscle relaxant
0,157  0,029  NAT2 substrate
0,138  0,012  Phosphodiesterase III inhibitor
0,145  0,020  Acetylcholine release stimulant
0,239  0,121  CTGF expression inhibitor
0,214  0,096  Acute neurologic disorders treatment
0,247  0,130  Vasodilator, peripheral
0,225  0,110  5 Hydroxytryptamine uptake stimulant
0,217  0,104  Cardiotonic
0,168  0,056  Antiparkinsonian, tremor relieving
0,147  0,037  5 Hydroxytryptamine 3A agonist
0,235  0,125  Mood disorders treatment
0,239  0,130  Antihypertensive
0,223  0,114  Gastrin inhibitor
0,144  0,035  Protein kinase C gamma inhibitor
0,173  0,066  Aldehyde oxidase substrate
0,136  0,029  Vasculitis treatment
0,120  0,015  Narcolepsy treatment
0,171  0,068  Muscular dystrophy treatment
0,157  0,057  Antianemic
0,158  0,058  CNS active muscle relaxant
0,187  0,089  Pyruvate kinase inhibitor
0,139  0,042  Excitatory amino acid transporter EAAC1 inhibitor
0,218  0,121  Antiepileptic
0,295  0,200  Caspase 9 stimulant
0,105  0,012  Antidote, organophosphates
0,228  0,135  GST M1-1 substrate
0,152  0,060  Cytokine production inhibitor
0,101  0,010  Glutamate (mGluR7) antagonist
0,098  0,008  Antihemophilic
0,203  0,113  DNA damaging
0,186  0,098  Cardiodepressant
0,098  0,010  Factor IXa inhibitor
0,111  0,024  Cyclin B3 inhibitor
0,098  0,012  Phosphodiesterase 3B inhibitor
0,143  0,057  Antiprotozoal (Trichomonas)
0,128  0,044  Alpha adrenoreceptor antagonist
0,097  0,015  Phosphodiesterase 1B inhibitor
0,091  0,009  Poly(ADP-ribose) polymerase inhibitor
0,148  0,068  Cell wall synthesis inhibitor
0,188  0,108  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,157  0,079  Antiviral (Hepatitis C)
0,117  0,039  Electrolyte absorption antagonist
0,100  0,023  Adenosine A1 receptor antagonist
0,202  0,125  UGT1A9 substrate
0,187  0,112  Aldehyde oxidase inhibitor
0,175  0,100  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,118  0,045  Gastric antisecretory
0,212  0,139  Insulysin inhibitor
0,148  0,076  Acetylcholine M1 receptor antagonist
0,089  0,018  Phosphodiesterase 4C inhibitor
0,196  0,125  5 Hydroxytryptamine release stimulant
0,141  0,071  Heat shock protein 70 antagonist
0,155  0,086  Cyclin-dependent kinase 3 inhibitor
0,078  0,009  Poly(ADP-ribose) polymerase 1 inhibitor
0,150  0,083  Carcinogenic, group 1
0,154  0,088  Muscle relaxant
0,083  0,016  Phosphodiesterase II inhibitor
0,095  0,032  Acetylcholine M4 receptor antagonist
0,125  0,063  DNA repair enzyme inhibitor
0,148  0,088  Uterine stimulant
0,176  0,117  Aryl hydrocarbon receptor agonist
0,085  0,028  MAP kinase 7 inhibitor
0,062  0,005  Angiotensin AT1 receptor antagonist
0,098  0,042  Bromodomain-containing protein 2 inhibitor
0,108  0,052  GABA C receptor rho-1 antagonist
0,088  0,033  Benzodiazepine agonist
0,138  0,083  Ca2+-transporting ATPase inhibitor
0,071  0,017  Phosphodiesterase 2A inhibitor
0,100  0,046  Carcinogenic, group 2A
0,081  0,028  Protein kinase C beta inhibitor
0,086  0,034  HIV-1 integrase inhibitor
0,060  0,008  Alpha 1L adrenoreceptor agonist
0,227  0,175  Calcium channel activator
0,139  0,088  Phospholipase A2 inhibitor
0,142  0,092  UGT1A4 substrate
0,074  0,024  Phosphodiesterase 1C inhibitor
0,101  0,051  Phosphodiesterase 6D inhibitor
0,102  0,053  Prolactin inhibitor
0,135  0,086  Genotoxic
0,197  0,148  Antidepressant
0,054  0,005  Angiotensin II receptor antagonist
0,094  0,046  Antileprosy
0,119  0,071  Antiprotozoal (Amoeba)
0,136  0,089  Insulin secretagoues
0,089  0,044  Caspase 7 inhibitor
0,115  0,071  Antineoplastic antimetabolite
0,095  0,051  Antidote, mercury
0,073  0,030  MDM2 inhibitor
0,193  0,151  Antihypoxic
0,109  0,067  GABA receptor agonist
0,143  0,101  Hearing loss treatment
0,089  0,049  Histamine H1 receptor antagonist
0,075  0,036  5 Hydroxytryptamine 3A antagonist
0,089  0,050  Myeloperoxidase inhibitor
0,169  0,129  Antiviral (Ebola)
0,138  0,099  Prostatic (benign) hyperplasia treatment
0,091  0,052  Tocolytic
0,198  0,160  Nootropic
0,077  0,040  Alpha adrenoreceptor agonist
0,167  0,130  Urologic disorders treatment
0,118  0,082  Gastritis treatment
0,056  0,021  Thymidylate synthase inhibitor
0,230  0,195  CYP2C19 inhibitor
0,069  0,036  5 Hydroxytryptamine 3 agonist
0,153  0,120  Antirickettsial
0,208  0,176  CYP3A4 substrate
0,073  0,041  Acetylcholine M5 receptor agonist
0,107  0,076  TRPA1 agonist
0,096  0,065  Antifungal (Candida)
0,092  0,062  Protein kinase C zeta inhibitor
0,062  0,033  Protein kinase C eta inhibitor
0,169  0,140  5 Hydroxytryptamine 3E antagonist
0,038  0,009  Thiazolidinedione
0,065  0,037  Alpha 2 adrenoreceptor agonist
0,068  0,040  5 Hydroxytryptamine 1D antagonist
0,083  0,056  Antiviral (RSV)
0,184  0,157  Radiosensitizer
0,064  0,037  Cyclin D1 inhibitor
0,084  0,057  GABA A receptor agonist
0,110  0,084  Cholinergic antagonist
0,190  0,164  Prostaglandin dehydrogenase inhibitor
0,062  0,037  Heat shock protein 90 beta antagonist
0,047  0,022  Nerve growth factor antagonist
0,074  0,050  Lipase inhibitor
0,053  0,029  AMPA receptor antagonist
0,146  0,122  Antiviral (Hepatitis)
0,069  0,046  SULT2A1 substrate
0,141  0,120  UGT2B10 substrate
0,099  0,079  Antifungal (Aspergillus)
0,058  0,038  Alpha 1 adrenoreceptor agonist
0,095  0,076  Falcipain 3 inhibitor
0,130  0,111  Pulmonary hypertension treatment
0,034  0,015  Poly(ADP-ribose) polymerase 2 inhibitor
0,110  0,092  Antifungal (Pneumocystis)
0,046  0,029  Parathyroid hormone antagonist
0,188  0,171  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,144  0,127  UGT1A1 substrate
0,089  0,072  Phosphodiesterase 7B inhibitor
0,052  0,035  5 Hydroxytryptamine 2 agonist
0,070  0,053  Alpha 1b adrenoreceptor antagonist
0,045  0,028  Dihydrofolate reductase inhibitor
0,177  0,161  CYP2C19 substrate
0,036  0,020  Adenosine uptake inhibitor
0,104  0,088  Acetylcholine antagonist
0,091  0,075  Nitric-oxide synthase inhibitor
0,145  0,130  Phobic disorders treatment
0,064  0,048  Uterine relaxant
0,080  0,066  Alpha 2 adrenoreceptor antagonist
0,183  0,168  UGT2B4 substrate
0,040  0,026  Alpha 1d adrenoreceptor agonist
0,094  0,080  Alpha 2b adrenoreceptor antagonist
0,111  0,097  Toll-Like receptor 9 antagonist
0,122  0,109  Urolithiasis treatment
0,166  0,152  Antipsychotic
0,179  0,166  Antiviral (West Nile virus)
0,174  0,161  Cardioprotectant
0,074  0,062  Acetylcholine nicotinic antagonist
0,150  0,137  Potassium channel (Voltage-sensitive) blocker
0,105  0,092  Shock treatment
0,038  0,025  Delayed rectifier potassium channel blocker
0,036  0,025  5 Hydroxytryptamine 3B antagonist
0,069  0,058  Alpha 2a adrenoreceptor antagonist
0,071  0,061  Vanilloid 4 agonist
0,054  0,043  Immunoglobulin Fc receptor antagonist
0,111  0,101  Antihelmintic (Trematoda)
0,060  0,051  5 Hydroxytryptamine 1B antagonist
0,036  0,027  Somatostatin 4 agonist
0,167  0,159  RNA-directed DNA polymerase inhibitor
0,082  0,075  Antihistaminic
0,057  0,050  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,040  0,034  GABA B receptor antagonist
0,049  0,043  Histamine agonist
0,075  0,070  Phosphodiesterase XI inhibitor
0,075  0,070  Phosphodiesterase 11A inhibitor
0,010  0,005  Corticotropin releasing factor antagonist
0,050  0,045  Nicotinic receptor alpha7 subunit antagonist
0,154  0,149  UGT1A6 substrate
0,110  0,105  Antifungal enhancer
0,072  0,068  Acetylcholine nicotinic agonist
0,098  0,093  Acetylcholine muscarinic antagonist
0,144  0,141  Insulin sensitizer
0,045  0,042  Phosphatidylinositol 3-kinase beta inhibitor
0,062  0,059  Endocannabinoid uptake inhibitor
0,025  0,023  5 Hydroxytryptamine 1D agonist
0,099  0,098  Interleukin 8 antagonist

